The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes

Insights

Juvenile psoriatic arthritis (JPsA) patients may be divided into two groups based on age at onset. While objective symptoms improved, patient-reported outcomes did not, suggesting a need to unify JPsA and adult psoriatic arthritis classification criteria.

Area of Science:

  • Rheumatology
  • Pediatric Rheumatology
  • Clinical Immunology

Background:

  • Juvenile psoriatic arthritis (JPsA) is a complex condition requiring precise classification.
  • Current classification criteria, including the International League of Associations for Rheumatology (ILAR) and Classification criteria for Psoriatic Arthritis (CASPAR), may not fully capture all pediatric cases.

Purpose of the Study:

  • To analyze demographic and clinical features of children with JPsA.
  • To compare JPsA patients classified by ILAR and CASPAR criteria.
  • To investigate the relationship between age at disease onset and clinical presentation in JPsA.

Main Methods:

  • Cross-sectional analysis of 361 children in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.
  • Stratification of patients by age at disease onset (≤ or > 4 years).
  • Comparison of baseline and 1-year follow-up data using statistical tests.

Main Results:

  • 72.02% of patients had symptom onset after 4 years of age, with male predominance and high enthesitis prevalence.
  • Statistically significant improvements were observed in arthritis, dactylitis, enthesitis, psoriasis, sacroiliitis, and nail pitting at follow-up.
  • Patients meeting CASPAR criteria but not ILAR criteria showed more enthesitis, sacroiliitis, inflammatory bowel disease, and uveitis, with less psoriasis.

Conclusions:

  • JPsA patients can be divided into two clinical subgroups based on age at disease onset.
  • Objective symptom improvement did not correlate with health questionnaire scores.
  • Unifying adult and pediatric psoriatic arthritis classification criteria should be considered, as current pediatric criteria may not identify all children meeting adult criteria.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
842
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
564
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
675
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K